S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
66,000% upside on tiny biotech? (Ad)
Attorney says West Virginia governor refusing to pay judgment in coal lawsuit
Court battle over interstate travel targets Utah bus stops in Nevada, California
Buy THIS stock before Taiwan is attacked (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Buy THIS stock before Taiwan is attacked (Ad)
Tragedy that left 5 dead or missing puts spotlight on safety in Alaska charter fishing industry
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
66,000% upside on tiny biotech? (Ad)
Attorney says West Virginia governor refusing to pay judgment in coal lawsuit
Court battle over interstate travel targets Utah bus stops in Nevada, California
Buy THIS stock before Taiwan is attacked (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Buy THIS stock before Taiwan is attacked (Ad)
Tragedy that left 5 dead or missing puts spotlight on safety in Alaska charter fishing industry
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
66,000% upside on tiny biotech? (Ad)
Attorney says West Virginia governor refusing to pay judgment in coal lawsuit
Court battle over interstate travel targets Utah bus stops in Nevada, California
Buy THIS stock before Taiwan is attacked (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Buy THIS stock before Taiwan is attacked (Ad)
Tragedy that left 5 dead or missing puts spotlight on safety in Alaska charter fishing industry
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
66,000% upside on tiny biotech? (Ad)
Attorney says West Virginia governor refusing to pay judgment in coal lawsuit
Court battle over interstate travel targets Utah bus stops in Nevada, California
Buy THIS stock before Taiwan is attacked (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Buy THIS stock before Taiwan is attacked (Ad)
Tragedy that left 5 dead or missing puts spotlight on safety in Alaska charter fishing industry
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
NYSE:ENFN

Enfusion (ENFN) Earnings Date, Estimates & Call Transcripts

$8.09
+0.28 (+3.59%)
(As of 06/2/2023 ET)
Compare
Today's Range
$7.78
▼
$8.25
50-Day Range
$7.54
▼
$10.50
52-Week Range
$7.37
▼
$16.76
Volume
1.05 million shs
Average Volume
484,292 shs
Market Capitalization
$940.79 million
P/E Ratio
202.30
Dividend Yield
N/A
Price Target
$11.08
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Aug. 8Estimated
Actual EPS
(May. 9)
$0.04 Beat By $0.03
Consensus EPS
(May. 9)
$0.01
Last Year's Q2 EPS
(5/12/2022)
$0.03
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

ENFN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ENFN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Enfusion Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20232$0.07$0.09$0.08 
Q2 20232$0.07$0.09$0.08 
Q3 20232$0.09$0.10$0.10 
Q4 20232$0.09$0.11$0.10 
FY 20238$0.32$0.39 $0.36

ENFN Earnings Date and Information

Enfusion last issued its quarterly earnings results on May 9th, 2023. The reported $0.04 earnings per share for the quarter, topping the consensus estimate of $0.01 by $0.03. The company earned $40.97 million during the quarter, compared to analysts' expectations of $41.99 million. Enfusion has generated $0.04 earnings per share over the last year ($0.04 diluted earnings per share) and currently has a price-to-earnings ratio of 202.3. Earnings for Enfusion are expected to grow by 66.67% in the coming year, from $0.12 to $0.20 per share. Enfusion has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 8th, 2023 based off prior year's report dates.

Enfusion Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/8/2023
(Estimated)		        
5/9/2023Q1 2023$0.01$0.04+$0.03$0.04$41.99 million$40.97 million
3/7/2023Q4 2022$0.01+$0.01$0.01$39.88 million$40.52 million
11/10/2022Q3 2022($0.03)$0.02+$0.05$0.02$38.52 million$39.15 million
8/9/2022Q2 2022($0.04)($0.03)+$0.01($0.03)$35.67 million$36.54 million
5/12/2022Q1 2022$0.04$0.03($0.01)$0.16$33.01 million$34.14 million
3/24/2022Q4 2021$0.04$0.55+$0.51$3.36$30.52 million$31.85 million    












Enfusion Earnings - Frequently Asked Questions

When is Enfusion's earnings date?

Enfusion has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 8th, 2023 based off last year's report dates. Learn more on ENFN's earnings history.

Did Enfusion beat their earnings estimates last quarter?

In the previous quarter, Enfusion (NYSE:ENFN) reported $0.04 earnings per share (EPS) to beat the analysts' consensus estimate of $0.01 by $0.03. Learn more on analysts' earnings estimate vs. ENFN's actual earnings.

How much revenue does Enfusion generate each year?

Enfusion (NYSE:ENFN) has a recorded annual revenue of $150.35 million.

How much profit does Enfusion generate each year?

Enfusion (NYSE:ENFN) has a recorded net income of -$7.65 million. ENFN has generated $0.04 earnings per share over the last four quarters.

What is Enfusion's price-to-earnings ratio?

Enfusion (NYSE:ENFN) has a trailing price-to-earnings ratio of 202.30 and a forward price-to-earnings ratio of 67.42. The price/earnings-to-growth ratio is 1.32.

What is Enfusion's EPS forecast for next year?

Enfusion's earnings are expected to grow from $0.12 per share to $0.20 per share in the next year, which is a 66.67% increase.

More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NYSE:ENFN) was last updated on 6/3/2023 by MarketBeat.com Staff

My Account -